Sirna-027
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sirna-027, covering 2008-08-18 to 2008-08-18. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]